Cell Death in Pulmonary Arterial Hypertension

被引:2
|
作者
Li, Xia [1 ,2 ,3 ]
Tan, Junlan [2 ,3 ]
Wan, Jiajing [2 ,3 ]
Cheng, Beibei [2 ,3 ]
Wang, Yu-Hong [4 ]
Dai, Aiguo [1 ,2 ,3 ]
机构
[1] Hunan Acad Chinese Med, Changsha 410208, Hunan, Peoples R China
[2] Hunan Univ Chinese Med, Med Sch, Dept Resp Dis, Changsha 410208, Hunan, Peoples R China
[3] Hunan Prov Key Lab Vasc Biol & Translat Med, Changsha 410208, Hunan, Peoples R China
[4] Hunan Univ Chinese Med, Sci & Technol Innovat Ctr, Changsha 410208, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
pulmonary arterial hypertension; pulmonary artery smooth muscle cells; pulmonary artery endothelial cells; cell death; MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; NITRIC-OXIDE; CHRONIC HYPOXIA; SENESCENCE; AUTOPHAGY; APOPTOSIS; DISEASE; PROLIFERATION;
D O I
10.7150/ijms.93902
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular disease characterized by increased pulmonary vascular resistance because of vascular remodeling and vasoconstriction. Subsequently, PAH leads to right ventricular hypertrophy and heart failure. Cell death mechanisms play a significant role in development and tissue homeostasis, and regulate the balance between cell proliferation and differentiation. Several basic and clinical studies have demonstrated that multiple mechanisms of cell death, including pyroptosis, apoptosis, autophagy, ferroptosis, anoikis, parthanatos, and senescence, are closely linked with the pathogenesis of PAH. This review summarizes different cell death mechanisms involved in the death of pulmonary artery smooth muscle cells (PASMCs) and pulmonary artery endothelial cells (PAECs), the primary target cells in PAH. This review summarizes the role of these cell death mechanisms, associated signaling pathways, unique effector molecules, and various pro-survival or reprogramming mechanisms. The aim of this review is to summarize the currently known molecular mechanisms underlying PAH. Further investigations of the cell death mechanisms may unravel new avenues for the prevention and treatment of PAH.
引用
收藏
页码:1840 / 1851
页数:12
相关论文
共 50 条
  • [21] Maternal Death Due to Pulmonary Arterial Hypertension - A Nationwide Survey in Japan -
    Aoki-Kamiya, Chizuko
    Katsuragi, Shinji
    Shiina, Yumi
    Hasegawa, Junichi
    Yoshimatsu, Jun
    Nakai, Akihito
    Ishiwata, Isamu
    Sekizawa, Akihiko
    Ikeda, Tomoaki
    CIRCULATION JOURNAL, 2025, 89 (01) : 77 - 82
  • [22] Pulmonary arterial hypertension predicts death in diffuse cutaneous systemic sclerosis
    Rachel Murphy
    Nature Clinical Practice Rheumatology, 2006, 2 (5): : 235 - 236
  • [23] Pluripotent stem cell modeling of pulmonary arterial hypertension
    Qian, L.
    Karavenzas, K.
    Cheung, M.
    Stanley, E.
    Elliott, D. A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A98 - A99
  • [24] Stem cell therapy for pulmonary arterial hypertension: An update
    Sun, Qiwei Wilton
    Sun, Zhongjie
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (06): : 692 - 703
  • [25] Right Ventricular Stemi as a Cause of Death in Idiopathic Pulmonary Arterial Hypertension
    Zhan, Yang
    Burstein, Barry
    Abualsaud, Ali
    Nosair, Mohamed
    Langleben, David
    CIRCULATION, 2016, 134
  • [26] Pulmonary Hypertension/Pulmonary arterial Hypertension in congenital Heart Disease and Therapy of pulmonary arterial Hypertension in Children
    Gorenflo, M.
    Apitz, C.
    Miera, O.
    Stiller, B.
    Schranz, D.
    Berger, F.
    Hager, A.
    Kaemmerer, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S166 - S170
  • [27] Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
    Hautefort, Aurelie
    Chesne, Julie
    Preussner, Jens
    Pullamsetti, Soni S.
    Tost, Jorg
    Looso, Mario
    Antigny, Fabrice
    Girerd, Barbara
    Riou, Marianne
    Eddahibi, Saadia
    Deleuze, Jean-Francois
    Seeger, Werner
    Fadel, Elie
    Simonneau, Gerald
    Montani, David
    Humbert, Marc
    Perros, Frederic
    ONCOTARGET, 2017, 8 (32) : 52995 - 53016
  • [28] Pulmonary arterial hypertension
    Reichenberger, F.
    Voswinckel, R.
    INTERNIST, 2011, 52 (04): : 405 - 414
  • [29] Pulmonary arterial hypertension
    Tapson, VF
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (04) : 353 - 354
  • [30] Pulmonary (Arterial) Hypertension
    Kwapiszewska, G.
    Hoffmann, J.
    Kovacs, G.
    Stacher, E.
    Olschewski, A.
    Olschewski, H.
    PNEUMOLOGIE, 2016, 70 (10): : 630 - 637